« Exploring a therapeutic target under its physiological conditions yields crucial information for developing highly effective molecules, while at the same time significantly reducing their side effects. Our proprietary technologies enable us to achieve this feat. »
Dr Pierre Eftekhari, President
We are dedicated to the development of technologies aiming at improving lead compound selection and decreasing attrition rates during drug development by better predicting drug effects and toxicity.
LEARN MORE
Pharma companies can use these technologies for lead compound selection enabling innovative, efficient and fast drug development. Our customers are any public or private organisations involved in the discovery and development of innovative drugs.
LEARN MORE
